Sartorius Stedim Biotech S.A. Unsponsored ADR (SRTOY)
OTC
Closed
Aug 24, 2026
Day's Range
22.4552 wk Range
17.25Overview - SRTOY - Sartorius Stedim Biotech S.A. Unsponsored ADR
Key Statistics
Valuation
Enterprise Value
28.17B
P/E (Trailing)
‪64.67‬
PEG Ratio
‪7.11‬
Price / Sales (TTM)
‪7.32‬
Price / Book
‪4.49‬
EV / EBITDA
‪29.56‬
Profitability
Gross Margin
‪46.85%‬
Profit Margin
‪9.73%‬
Operating Margin
‪20.11%‬
Return on Assets
‪4.39%‬
Return on Equity
‪7.08%‬
Ownership
Shares Outstanding
97.29M
Float
276.15M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.13‬
50-Day Avg
‪20.17‬
200-Day Avg
‪21.35‬
Dividends
Payout Ratio
‪23.06%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SRTOY - Sartorius Stedim Biotech S.A. Unsponsored ADR
Peers - SRTOY - Sartorius Stedim Biotech S.A. Unsponsored ADR
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on OTC.
Profile Summary - SRTOY - Sartorius Stedim Biotech S.A. Unsponsored ADR
About
Sartorius Stedim Biotech S.A. Unsponsored ADR represents equity interests in Sartorius Stedim Biotech S.A., a global provider of advanced products and solutions for the biopharmaceutical industry. Specializing in technologies that support the research, development, and manufacturing of biotech medicines and vaccines,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
